hTERT DNA vaccine (Invectys)

N/A

Report date: 2025/12/19 20:01:35

Base Information

Drug NamehTERT DNA vaccine (Invectys)
Drug Alias NamehTERT DNA immunotherapyHuman telomerase reverse transcriptase DNA vaccineINVAC-1
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsTelomerase inhibitors
TargetsTelomerase
Therapy Area/IndicationsSolid tumoursLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInvectys
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvectys
Active IndicationsN/A
Inactive IndicationsSolid tumoursLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A